The people left behind: refining priorities for health care during and after the pandemic
June 26, 2020 | 10.4244/EIJY20M06-01
Showing 1-3 of 3 articles
Polymer-free drug-coated coronary stents are cost-effective in patients at high bleeding risk: economic evaluation of the LEADERS FREE trial
February 20, 2018 | 10.4244/EIJ-D-17-00286
Coronary interventions
The SYNERGY II Everolimus elutiNg stent In patients Older than 75 years undergoing coronary Revascularisation associated with a short dual antiplatelet therapy (SENIOR) trial: rationale and design of a large-scale randomised multicentre study January 20, 2017 | 10.4244/EIJY15M12_02